Toward countering muscle and bone loss with spaceflight: GSK3 as a potential target

Recent research is helping us understand how humans might cope with the challenges of living and working on long trips to places like Mars or back to the moon. One big problem we face in space? Our muscles get weak because there's no gravity, which can also affect our bones negatively over time. Scientists are trying out new ways to help astronauts stay healthy by studying mice that have been genetically modified and living on special missions designed for research (like BION-M1). In this study, scientists looked at how these unique muscle cells in the mice responded when they were exposed to space conditions. They found out some interesting things: even though there's no gravity, our bodies can still produce a lot of force with certain types of exercise that don't rely on weight-bearing (like using resistance bands). This is good news because it means we might be able to keep muscles strong in space. The researchers also discovered something about how genes work together, particularly one called Gsk3 and another named PGC-1a/f that are linked with bone health.

This research paper delves into the challenges of human survival and physiology during extended missions beyond low Earth orbit (LEO), with a particular focus on preparing for Mars expeditions by studying effects in lunar-like conditions. The study acknowledges that space radiation, isolation/confinement, distance from Earth, extreme environmental factors such as temperature and pressure variations, microgravity exposure are significant hazards identified by NASA during human spaceflight endeavors. To address these concerns, the researchers employed experimental models involving muscle samples collected post-mission (RR1, RR9, RR18) from previous lunar missions and BION-M1 experiments aboard ISS to investigate changes in muscle force production under microgravity conditions. The study also explored potential protective mechanisms against spaceflight-induced declines by examining the role of Gsk3 deletion on maintaining bone mass through increased PGC-1a and FNDC5 expression levels, which are crucial for musculoskeletal health during extended missions.